Aurobindo Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Aurobindo Pharma Ltd. from all sources in a single place.

Load latest

Aurobindo Pharma Ltd.

30 Sep 2024

1115.60

-0.41%

Aurobindo Pharma subsidiary gets 10 observations from USFDA for API plant

Business Standard

Aurobindo Pharma on Monday said the US health regulator has issued 10 observations after inspecting the API facility of its subsidiary in Telangana. The US Food and Drug Administration (USFDA) inspected Unit-II, an active pharmaceutical ingredients (API) manufacturing facility of Apitoria Pharma, a wholly-owned subsidiary of the company, in Sangareddy district from September 23-27, 2024, the Hyderabad-based drug maker said in a regulatory filing. The inspection closed with 10 observations, it added. The observations are procedural in nature and will be responded to within the stipulated time, the drug maker stated. Shares of Aurobindo Pharma on Monday ended 3.16 per cent down at Rs 1,462 apiece on BSE.

Number of FII/FPI investors decreased from 730 to 724 in Mar 2025 qtr

Aurobindo Pharma Share Price Declines After US FDA Issues 10 Observations For Telangana Facility

NDTV Profit | 30 Sep 2024 1 more

Aurobindo Pharma Ltd.

30 Sep 2024

1115.60

-0.41%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Unit II Of Apitoria …

BSE India

Intimation of completion of US FDA Audit at Unit II of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company.

pdf

Aurobindo Pharma Ltd.

25 Sep 2024, 10:17AM

1115.60

-0.41%

SAST

AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window

BSE India

Intimation of Closure of Trading window.

pdf

Aurobindo Pharma Ltd.

19 Sep 2024

1115.60

-0.41%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation investors meet to be held on September 24, 2024.

pdf

Aurobindo Pharma Ltd.

18 Sep 2024

1115.60

-0.41%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation of entering into a binding agreement for acquiring balance 49% equity shares in GLS Pharma Limited, a subsidiary of the Company.

pdf

Aurobindo Pharma Ltd.

18 Sep 2024

1115.60

-0.41%

Aurobindo Pharma arm receives EIR from USFDA for Andhra Unit; stock down 2%

Business Standard

Aurobindo Pharma shares fell following the news that the US Food and Drug Administration has issued the Establishment Inspection Report (EIR) for the new injectable facility of Eugia Steriles

Aurobindo Pharma Ltd. has an average target of 1493.80 from 10 brokers.

Aurobindo Pharma Ltd.

18 Sep 2024

1115.60

-0.41%

Company Update

AUROBINDO PHARMA LTD. - 524804 - New Injectable Facility Of Eugia Steriles Private Limited, A 100% …

BSE India

Submission of receipt of Establishment Inspection Report from USFDA for new injectable facility of Eugia Steriles Private Limited, a 100% step-down subsidiary company.

pdf

Aurobindo Pharma Ltd.

13 Sep 2024

1115.60

-0.41%

SAST

AUROBINDO PHARMA LTD. - 524804 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

pdf